NEW YORK, NY / ACCESSWIRE / January 24, 2019 / U.S. equities regained its footing on Wednesday on the back of strong corporate earnings. Overall profits of the companies who have reported quarterly results so far have risen by approximately by 13.2 percent. The Dow Jones Industrial Average closed up by 0.7 percent to settle at 24,575.62, supported by strong quarterly earnings from Procter & Gamble, IBM and United Technologies, while the S&P 500 climbed 0.22 percent to close at 2,638.70. The Nasdaq barely moved by 0.08 percent higher to close at 7,025.77.
"Ultimately, when you look at the data, the thing that matters most to the market is earnings," said the founder of Zoe Financial, Andres Garcia-Amaya. "I would say the technology sector is one that could make or break the story for equities. If you look at margins for the sector versus the other sectors, it's by far the largest," he added.
The Market Wealth Report Initiates Coverage on:
Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries’ stock jumped 3.79% Wednesday, to close the day at $19.46. The stock recorded a trading volume of 10,428,002 shares, which was below its three months average volume of 11,332,324 shares. In the last year, Teva Pharmaceutical Industries’ shares have traded in a range of 14.59 - 25.96. The share price has gained 33.38% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $17.77 is below its 200-day moving average of $21.39. Shares of Teva Pharmaceutical Industries have gained roughly 33.38 percent in the past month and are up 26.2 percent year-to-date.
Access The Market Wealth's Teva Pharmaceutical Industries LimitedResearch Report:
On Wednesday, shares of AstraZeneca recorded a trading volume of 7,918,908 shares, which was above the three months average volume of 5,020,122 shares. The stock ended the day 1.16% higher at $36.69. The share price has fallen 12.18% from its 52 week high with a 52 week trading range of 32.69 - 41.78. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $37.83 is below its 200-day moving average of $38.41. Shares of the company are trading at a Price to Earnings ratio of 38.42. Shares of AstraZeneca have fallen roughly 0.46 percent in the past month and are down 3.4 percent year-to-date.
Access The Market Wealth's AstraZeneca PLC Research Report:
The Market Wealth Report
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Wealth Report has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketWealthReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketWealthReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketwealthreport.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
The Market Wealth Report, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Wealth Report